Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration-Reference-Cited by-同舟云学术

Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration

Author:

Freedland Stephen J.¹²^ORCID,Sandin Rickard³,Sah Janvi⁴,Emir Birol⁵,Mu Qiao⁴,Ratiu Anna⁴,Hong Agnes⁶,Serfass Lucile⁷,Tagawa Scott T.⁸

Affiliation:

1. Division of Urology Department of Surgery Cedars‐Sinai Medical Center Los Angeles California USA

2. Veterans Affairs Health Care System Durham North Carolina USA

3. Pfizer AB Sollentuna Sweden

4. STATinMED Research Ann Arbor Michigan USA

5. Pfizer Inc. New York New York USA

6. Astellas Inc. Northbrook Illinois USA

7. Pfizer Inc. Paris France

8. Division of Hematology & Medical Oncology and Department of Urology Weill Cornell Medicine New York Presbyterian Hospital New York New York USA

Funder

Astellas Pharma US

Pfizer

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

Reference29 articles.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献